| Authors: |
Yared JA; Department of Medicine, Division of Hematology/Oncology, Transplant & Cellular Therapy Program, Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, MD, USA., Fromowitz A; Department of Medicine, Division of Hematology/Oncology, Transplant & Cellular Therapy Program, Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, MD, USA., Kocoglu M; Department of Medicine, Division of Hematology/Oncology, Transplant & Cellular Therapy Program, Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, MD, USA., Hardy N; Department of Medicine, Division of Hematology/Oncology, Transplant & Cellular Therapy Program, Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, MD, USA., Atanackovic D; Department of Medicine, Division of Hematology/Oncology, Transplant & Cellular Therapy Program, Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, MD, USA., Rapoport AP; Department of Medicine, Division of Hematology/Oncology, Transplant & Cellular Therapy Program, Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, MD, USA. |
